Global PCSK9 Inhibitors Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 PCSK9 Inhibitors Industry
  • 1.1.1 Overview
  • 1.1.2 Development of PCSK9 Inhibitors
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 PCSK9 Inhibitors Market by Type

• 3.1 By Type
  • 3.1.1 Epatha Evolocumab
  • 3.1.2 Praluent Alirocumab
  • 3.1.3 Bococizumab
  • 3.1.4 Others
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.PCSK9 Inhibitors Amgen (Company Profile, Sales Data etc.)

• 4.2 Eli Lilly (Company Profile, Sales Data etc.)
• 4.3 Sanofi (Company Profile, Sales Data etc.)
• 4.4 Pfizer (Company Profile, Sales Data etc.)
• 4.5 Novartis (Company Profile, Sales Data etc.)
• 4.6 Roche (Company Profile, Sales Data etc.)
• 4.7 Merck (Company Profile, Sales Data etc.)
• 4.8 Alnylam (Company Profile, Sales Data etc.)
• 4.9 AstraZeneca (Company Profile, Sales Data etc.)
• 4.10 Affiris (Company Profile, Sales Data etc.)
• 4.11 BMS (Company Profile, Sales Data etc.)
• 4.12 Ionis Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.13 Cyon Therapeutics (Company Profile, Sales Data etc.)
• 4.14 Daiichi Sankyo (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Clinical Application
  • 6.1.2 Demand in Drug Development
  • 6.1.3 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of PCSK9 Inhibitors

Table Application Segment of PCSK9 Inhibitors

Table Global PCSK9 Inhibitors Market 2013-2024, by Application, in USD Million

Table Major Company List of Epatha Evolocumab

Table Major Company List of Praluent Alirocumab

Table Major Company List of Bococizumab

Table Major Company List of Others

Table Global PCSK9 Inhibitors Market 2013-2018, by Type, in USD Million

Table Global PCSK9 Inhibitors Market 2013-2018, by Type, in Volume

Table Global PCSK9 Inhibitors Market Forecast 2019-2024, by Type, in USD Million

Table Global PCSK9 Inhibitors Market Forecast 2019-2024, by Type, in Volume

Table Amgen Overview List

Table PCSK9 Inhibitors Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table PCSK9 Inhibitors Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi Overview List

Table PCSK9 Inhibitors Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table PCSK9 Inhibitors Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table PCSK9 Inhibitors Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche Overview List

Table PCSK9 Inhibitors Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck Overview List

Table PCSK9 Inhibitors Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Alnylam Overview List

Table PCSK9 Inhibitors Business Operation of Alnylam (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table PCSK9 Inhibitors Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Affiris Overview List

Table PCSK9 Inhibitors Business Operation of Affiris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table BMS Overview List

Table PCSK9 Inhibitors Business Operation of BMS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ionis Pharmaceuticals Overview List

Table PCSK9 Inhibitors Business Operation of Ionis Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cyon Therapeutics Overview List

Table PCSK9 Inhibitors Business Operation of Cyon Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Daiichi Sankyo Overview List

Table PCSK9 Inhibitors Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global PCSK9 Inhibitors Sales Revenue 2013-2018, by Company, in USD Million

Table Global PCSK9 Inhibitors Sales Revenue Share, by Company, in USD Million

Table Global PCSK9 Inhibitors Sales Volume 2013-2018, by Company, in Volume

Table Global PCSK9 Inhibitors Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table PCSK9 Inhibitors Demand Forecast 2019-2024, by Application, in USD Million

Table PCSK9 Inhibitors Demand Forecast 2019-2024, by Application, in Volume

Table PCSK9 Inhibitors Production 2013-2018, by Region, in USD Million

Table PCSK9 Inhibitors Production 2013-2018, by Region, in Volume

Table Global PCSK9 Inhibitors Market 2013-2018, by Region, in USD Million

Table Global PCSK9 Inhibitors Market Share 2013-2018, by Region, in USD Million

Table Global PCSK9 Inhibitors Market 2013-2018, by Region, in Volume

Table Global PCSK9 Inhibitors Market Share 2013-2018, by Region, in Volume

Table North America PCSK9 Inhibitors Market Size 2013-2018, by Country, in USD Million

Table North America PCSK9 Inhibitors Market Size 2013-2018, by Country, in Volume

Table Europe PCSK9 Inhibitors Market Size 2013-2018, by Country, in USD Million

Table Europe PCSK9 Inhibitors Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific PCSK9 Inhibitors Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific PCSK9 Inhibitors Market Size 2013-2018, by Country, in Volume

Table South America PCSK9 Inhibitors Market Size 2013-2018, by Country, in USD Million

Table South America PCSK9 Inhibitors Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa PCSK9 Inhibitors Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa PCSK9 Inhibitors Market Size 2013-2018, by Country, in Volume

Table PCSK9 Inhibitors Market Forecast 2019-2024, by Region, in USD Million

Table PCSK9 Inhibitors Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global PCSK9 Inhibitors Market Growth 2013-2018, by Type, in USD Million

Figure Global PCSK9 Inhibitors Market Growth 2013-2018, by Type, in Volume

Figure North America PCSK9 Inhibitors Market Concentration, in 2018

Figure Europe PCSK9 Inhibitors Market Market Concentration, in 2018

Figure Asia-Pacific PCSK9 Inhibitors MMarket Concentration, in 2018

Figure South America PCSK9 Inhibitors Market Concentration, in 2018

Figure Middle East & Africa PCSK9 Inhibitors Market Concentration, in 2018

Figure PCSK9 Inhibitors Demand in Clinical Application, 2013-2018, in USD Million

Figure PCSK9 Inhibitors Demand in Clinical Application, 2013-2018, in Volume

Figure PCSK9 Inhibitors Demand in Drug Development, 2013-2018, in USD Million

Figure PCSK9 Inhibitors Demand in Drug Development, 2013-2018, in Volume

Figure PCSK9 Inhibitors Demand in Others, 2013-2018, in USD Million

Figure PCSK9 Inhibitors Demand in Others, 2013-2018, in Volume

Figure North America PCSK9 Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure North America PCSK9 Inhibitors Market Size and Growth 2013-2018, in Volume

Figure Europe PCSK9 Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure Europe PCSK9 Inhibitors Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific PCSK9 Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific PCSK9 Inhibitors Market Size and Growth 2013-2018, in Volume

Figure South America PCSK9 Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure South America PCSK9 Inhibitors Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa PCSK9 Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa PCSK9 Inhibitors Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview